Part 1 | Part 2 | Part 3 |
Notifiable Diseases |
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | COVID-19 | Creutzfeld-Jacob disease (Classic and New Variant) |
Diphtheria | Cryptosporidiosis | Cytomegalovirus (congenital/neonatal) |
Human influenza caused by a new subtype | Cyclosporiasis | Gonococcal infection |
Measles | Escherichia coli infection (verotoxigenic) | Hepatitis C |
Meningococcal disease (invasive) | Giardiasis | Hepatitis G |
Multisystem inflammatory syndrome in children (MIS-C) | Guillain-Barré syndrome | Hepatitis (other viral) |
Plague | Hantavirus pulmonary syndrome | Herpes (congenital / neonatal) |
Poliomyelitis due to wild-type poliovirus | Haemophilus influenzae infection – all serotypes (invasive) | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Severe acute respiratory syndrome | Hepatitis A | Influenza (laboratory confirmed) |
Smallpox | Hepatitis B | Leprosy |
Yellow fever | Hepatitis E | Leptospirosis |
Viral Haemorrhagic fever | Legionellosis | Lyme borreliosis |
| Listeriosis (invasive) | Malaria |
| Mpox | Methicillin-resistant Staphylococcus aureus |
| Mumps | Pneumococcal infection (invasive) |
| Paralytic shellfish poisoning | Psittaccosis |
| Pertussis | Rickettsial infection |
| Q fever | Streptococcus group B infection (neonatal) |
| Rabies | Syphilis (including congenital) |
| Rubella (including congenital) | Tetanus |
| Salmonellosis | Toxoplasmosis |
| Shigellosis | Vancomycin-resistant Enterococci |
| Staphylococcus aureus foodborne intoxications | |
| Streptococcus group A infection (invasive) | |
| Tularemia | |
| Tuberculosis (active) | |
| Typhoid | |
| Varicella | |
| Vibrio species pathogenic to humans (other than Cholera) | |
| West Nile virus infection | |
| Yersinosis | |
Notifiable Events |
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | Suspect case of an existing or new variant of human or animal prion disease |
Clusters of severe or atypical illness thought to be respiratory-borne | | |